Aethlon Medical, Inc.
|Number of Estimates|
Aethlon Medical, Inc. is a therapeutic technology company, which focuses on addressing global health and biodefense needs. It develops Aethlon Hemopurifier, a medical device that targets the elimination of circulating viruses and tumor-secreted exosomes that promote cancer progression. The firm operates through two segments: Aethlon and ESI. The Aethlon segment involves in therapeutic business activities. The ESI segment consists of diagnostic business activities. The company was founded by James A. Joyce in May 1998 and is headquartered in San Diego, CA.
Market Cap: 6.66 Million
Primary Exchange: NASDAQ
Shares Outstanding: 3.23 Million
Float: 2.89 Million
Sector: Health Technology
Industry: Medical Specialties
Longest drawdown: 1825 trading days
From: 2014-11-24 To: 2020-01-17
|Ex-Date||Payment Date||Record Date||Declared Date||Amount||Flag||Dividend Type||Qualified||Indicated|
|Ex-Date||Declared Date||Record Date||Payment Date||Ratio||To Factor||For Factor|